The Valley Hospital Successfully Implants TriClip to Repair Leaky Tricuspid Heart Valves


Paramus, NJ, October 3, 2024 – The Valley Hospital’s structural heart team has successfully performed its first procedure using the Abbott TriClip? transcatheter edge-to-edge repair (TEER) system, the first-of-its-kind minimally invasive device to repair a leaky tricuspid valve (known as tricuspid regurgitation or TR), according to Abbott.

Tricuspid valve regurgitation is a condition in which the valve between the two right heart chambers (right ventricle and right atrium) do not close properly, allowing blood to flow backward into the right atrium of the heart. This debilitating condition can cause symptoms such as shortness of breath and fatigue, and, if untreated, may lead to more serious conditions such as atrial fibrillation, heart failure, or even sudden cardiac death.

Traditionally, treatment options for TR have been limited to high-risk surgeries or medical therapies that often fail to provide adequate relief. The FDA-approved Abbott TriClip now offers a novel, less invasive alternative.

The TriClip is delivered to the heart via a catheter inserted through the femoral vein in the leg, where it works by clipping the tricuspid valve leaflets together to reduce the backflow of blood. Designed specifically for the right side of the heart and the tricuspid valve’s complex anatomy, the innovative system enables physicians to independently grasp and clip the valve’s leaflets, improving heart efficiency and alleviating symptoms of TR.

“With the TriClip system, we now have a safer, minimally invasive approach to treat patients with tricuspid regurgitation,” said Rajiv Tayal, MD, Director of the Cardiac Catheterization Laboratory and Structural Heart Program at The Valley Hospital. “This device provides patients with a minimally invasive alternative to surgery, which can lead to improved heart function and quality of life.”

To learn more about structural heart care at Valley, please visit ValleyHealth.com/StructuralHeart.  

  • Currently 0.00/5
Rating: 0.00/5 (0 votes cast)

Share It!

Be the first to comment